Puma Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Yahoo! Finance
royalty revenue to $15.6M, with roughly $5.7M of sales reflecting an inventory build at specialty pharmacies. 2026 guidance : Puma expects net NERLYNX product revenue of $194–$198M, royalties of $20–$23M and full-year net income of $10–$13M, while warning gross-to-net adjustments will rise to about 27.5–28.5% and Q1 is typically seasonally weak. Clinical progress on alisertib : ALISCA-Breast1 reached enrollment ahead of schedule (164 patients) with interim data expected in Q2 2026, and ALISCA-Lung1 increased dosing to 60 mg BID (seeking a 70 mg amendment) after PK findings, with additional interim readouts due in Q2 2026. Interested in Puma Biotechnology, Inc.? Here are five stocks we like better. 3 small-cap biotechs with potential breakthroughs in 2024 Puma Biotechnology (NASDAQ:PBYI) reported fourth-quarter 2025 total revenue of $75.5 million, driven by NERLYNX product revenue and a sharp increase in royalty revenue, according to management's comments on the company's ear
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Puma Biotech: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
- Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care ConferenceBusiness Wire
PBYI
Earnings
- 2/26/26 - Beat
PBYI
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/20/26 - Form 4
- PBYI's page on the SEC website